Biotech · Private company
Knight Therapeutics (USA) Inc
Track this companyFree. Adds Knight Therapeutics (USA) Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MiltefosinePhase 2 · Mucosal LeishmaniasisClinicalTrials.gov · fetched Nov 12, 2026
- MiltefosineLeishmaniasisClinicalTrials.gov · fetched Nov 12, 2026
- MiltefosineLeishmaniasis or Other Uses of MiltefosineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy RegistryWITHDRAWN · started Jul 1, 2015ClinicalTrials.gov NCT02427308 · fetched Nov 12, 2026
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient RegistryWITHDRAWN · started Jul 1, 2015ClinicalTrials.gov NCT02429505 · fetched Nov 12, 2026
- Miltefosine to Treat Mucocutaneous LeishmaniasisPHASE2 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01050907 · fetched Nov 12, 2026